Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $8.16 USD
Change Today +0.31 / 3.95%
Volume 8.3M
ARIA On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

Earnings & Estimates Summary - ARIAD PHARMACEUTICALS INC (ARIA)

Ariad Pharmaceuticals Inc. to Report Q2, 2015 on Aug 05, 2015
CapIQ 08/05/2015 1:00 PM ET
Ariad Pharmaceuticals Inc. to Report Q1, 2015 on May 07, 2015
CapIQ 08/05/2015 1:00 PM ET
Ariad Pharmaceuticals Inc. to Report Q4, 2014 on Feb 19, 2015
CapIQ 08/05/2015 1:00 PM ET

2013 revenues at Ariad Pharmaceuticals Inc. totaled $45.6M USD, while annual losses equaled $1.49 per share.

Quarterly Earnings & Estimates - ARIAD PHARMACEUTICALS INC (ARIA)

Actuals vs. Estimates for ARIAD PHARMACEUTICALS INC ARIA

Ariad Pharmaceuticals Inc.'s Quarterly Earnings

Ariad Pharmaceuticals Inc. reported 2nd quarter 2014 losses of $0.30 per share on 08/8/2014.

Annual Earnings & Estimates - ARIAD PHARMACEUTICALS INC (ARIA)

Actuals vs. Estimates for ARIAD PHARMACEUTICALS INC ARIA

Ariad Pharmaceuticals Inc.'s Annual Earnings

Ariad Pharmaceuticals Inc. reported annual 2013 losses of $1.49 per share on 02/27/2014.

Quarterly Revenues - ARIAD PHARMACEUTICALS INC (ARIA)

Actuals vs. Estimates for ARIAD PHARMACEUTICALS INC ARIA

Ariad Pharmaceuticals Inc.'s Quarterly Revenues

Ariad Pharmaceuticals Inc. had 2nd quarter 2014 revenues of $12.1M USD. This missed the $13.6M USD consensus estimate of the 16 analysts following the company. This was -13.5% below the prior year's 2nd quarter results.

Annual Revenues - ARIAD PHARMACEUTICALS INC (ARIA)

Actuals vs. Estimates for ARIAD PHARMACEUTICALS INC ARIA

Ariad Pharmaceuticals Inc.'s Annual Revenues

Ariad Pharmaceuticals Inc. had revenues for the full year 2013 of $45.6M USD. This was 8,065.1% above the prior year's results.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ARIA:US $8.16 USD +0.31

ARIA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Arena Pharmaceuticals Inc $4.04 USD +0.07
Array BioPharma Inc $5.81 USD +0.06
Evotec AG €3.38 EUR -0.029
Exelixis Inc $5.73 USD +0.19
Pfizer Ltd/India 2,176 INR +53.85
View Industry Companies
 

Industry Analysis

ARIA

Industry Average

Valuation ARIA Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 13.0x
Price/Book 40.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales 9.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ARIAD PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.